An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Newsable Asianet News on MSN13h
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback